Business / Finance

RSS

Regenesis Biomedical closes $5.3M Series C equity financing

Regenesis Biomedical, Inc., a medical technology company that markets the Provant Therapy System, announced today the closing of a $5.3 million Series C equity financing.

7 Jun 2011

Brainlab enters into definitive agreement to acquire Voyant Health

Brainlab announced today that it has entered into a definitive agreement to acquire Voyant Health.

7 Jun 2011

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today announced the signing of a definitive merger agreement pursuant to which Merge Healthcare will acquire OIS.

6 Jun 2011

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy's Laboratories today announced that it has launched three products in the US market.

6 Jun 2011

Generex not to proceed with acquisition of interest in Global Medical Direct

Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.

6 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

Roper acquires Northern Digital

Roper Industries, Inc. today announced that it has completed the previously announced acquisition of Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications.

6 Jun 2011

Constellation raises $15M in Series B extension financing

Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced that it has raised $15 million in a Series B extension financing. All major current investors participated in the round, including Third Rock Ventures, The Column Group, Venrock Associates, SR One and Altitude Life Science Ventures.

6 Jun 2011

Global gene therapy market to reach $300 million by 2015

The global gene therapy market is expected to grow to over $300 million by 2015, according to a new report available on companiesandmarkets.com. The gene therapy market will grow further driven by the human genome project, the increasing incidence of cancer and other critical diseases.

6 Jun 2011

Crystal Research Associates report now available in MedPro website

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced the availability of a recently published research report prepared for the Company by Crystal Research Associates.

6 Jun 2011

The Ensign Group to acquire nine skilled nursing, assisted living facilities from Careage

The Ensign Group, Inc. announced today that Ensign operating subsidiaries have agreed to acquire nine skilled nursing and assisted living facilities from Sioux City, Iowa-based Careage Management, LLC. The acquisition is expected to become effective in July, 2011.

6 Jun 2011

Walgreen acquires drugstore.com

Walgreen Co. today announced that it has completed its acquisition of drugstore.com. The transaction includes all websites directly owned and operated by drugstore.com, as well as its corporate office and customer service and distribution center operations.

3 Jun 2011

AxoGen, LecTec sign merger agreement

LecTec Corporation announced today that on May 31, 2011 it entered into an Agreement and Plan of Merger ("Merger Agreement") with AxoGen Corporation, d/b/a AxoGen Inc., a privately held company focused on developing and commercializing medical products for the repair of peripheral nerve injuries.

3 Jun 2011

HHS inspector general: $3.4 billion recovered in first half of 2011

HHS' inspector general's office tallied $3.4 billion in expected recoveries through its audits and investigations in the first half of fiscal 2011, according to its semiannual report to Congress. The office recovered $3.1 billion in the year-ago period.

3 Jun 2011

New report: Life science tools market to reach over $80B by 2016

The life science tools market will reach over $80 billion by 2016, according to a new report on companiesandmarkets.com. The life science tools market has shown steady growth over the last couple of years despite the economic downturn.

3 Jun 2011

ANSTO, ITG partner to distribute radioisotopes

ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative radioisotopes, and Sydney-based, Australian Nuclear Science and Technology Organisation (ANSTO) have agreed on a broad, long-term collaboration on radioisotopes.

3 Jun 2011

HHS Secretary joins St. Paul’s Regions Hospital to highlight Partnership for Patients

On Thursday, June 2, 2011, U.S. Department of Health and Human Services Secretary Kathleen Sebelius will join hospital officials, doctors, patients, and other key health care advocates at Regions Hospital to highlight the Partnership for Patients.

3 Jun 2011

LabCorp extends cash tender offer for all shares of Orchid common stock

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 15, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc.

3 Jun 2011

Protox reports net and comprehensive loss of $2.2 million for first quarter 2011

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the quarter ended March 31, 2011.

2 Jun 2011

Bio-Tissue ships over 7,500 ProKera medical device since product's inception

Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera units since the product's inception. ProKera is the only medical device that can provide wound healing to over 350,000 annual cases of patients afflicted with damaged ocular surfaces.

2 Jun 2011